JAZZ PHARMA PLC revenue for the last year amounted to 3.23 B CHF, the most of which — 3.23 B CHF — came from its highest performing source at the moment, Pharmaceutical Products, the year earlier bringing 3.38 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought JAZZ PHARMA PLC 2.94 B CHF, and the year before that — 3.12 B CHF.